Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7974525rdf:typepubmed:Citationlld:pubmed
pubmed-article:7974525lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7974525lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:7974525lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:7974525lifeskim:mentionsumls-concept:C0040691lld:lifeskim
pubmed-article:7974525lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:7974525lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7974525lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:7974525lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:7974525pubmed:issue7lld:pubmed
pubmed-article:7974525pubmed:dateCreated1994-12-2lld:pubmed
pubmed-article:7974525pubmed:abstractTextIn order to better define potential mechanisms of growth regulation in human prostate cancer cells, we have compared biological responses (such as short-term response to both transforming growth factor alpha and beta; TFG alpha and TFG beta) in relation to hormone sensitivity of LNCaP, DU145, and PC3 cells. Androgen receptor (AR) and epidermal growth factor receptor (EGF-R) content of each cell line was also investigated. In addition, expression of EGF, TGF alpha, and TGF beta was evaluated through immunofluorescent staining. Growth of androgen non-responsive PC3 cells was stimulated by TGF alpha (about 35%) and inhibited by TGF beta (more than 50%), with respect to controls, after 48 h exposure. Conversely, AR-positive, hormone-responsive LNCaP cells proved to be poorly sensitive, at least short-term, to either growth factor. Furthermore, high levels of both EGF-R and TGF alpha, and a fairly high amount of EGF, were found in DU145 cells and, to a lesser extent, in LNCaP cells; in contrast, PC3 cells exhibited low expression levels of both receptors (EGF-R) and ligands (EGF, TGF alpha), but displayed remarkable TGF beta binding and relatively high levels of endogenous TGF beta. Overall, these results suggest a differential sensitivity to TGF alpha and TGF beta by prostate cancer cells; TGF alpha response seems not to be proportional to the EGF-R content of individual cell lines.lld:pubmed
pubmed-article:7974525pubmed:languageenglld:pubmed
pubmed-article:7974525pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7974525pubmed:citationSubsetIMlld:pubmed
pubmed-article:7974525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7974525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7974525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7974525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7974525pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7974525pubmed:statusMEDLINElld:pubmed
pubmed-article:7974525pubmed:monthJullld:pubmed
pubmed-article:7974525pubmed:issn0039-128Xlld:pubmed
pubmed-article:7974525pubmed:authorpubmed-author:LeakeR ERElld:pubmed
pubmed-article:7974525pubmed:authorpubmed-author:RinaldiFFlld:pubmed
pubmed-article:7974525pubmed:authorpubmed-author:Pavone-Macalu...lld:pubmed
pubmed-article:7974525pubmed:authorpubmed-author:ChalmersDDlld:pubmed
pubmed-article:7974525pubmed:authorpubmed-author:CastagnettaL...lld:pubmed
pubmed-article:7974525pubmed:authorpubmed-author:CarrubaGGlld:pubmed
pubmed-article:7974525pubmed:authorpubmed-author:SorceGGlld:pubmed
pubmed-article:7974525pubmed:authorpubmed-author:ComitoLLlld:pubmed
pubmed-article:7974525pubmed:issnTypePrintlld:pubmed
pubmed-article:7974525pubmed:volume59lld:pubmed
pubmed-article:7974525pubmed:ownerNLMlld:pubmed
pubmed-article:7974525pubmed:authorsCompleteYlld:pubmed
pubmed-article:7974525pubmed:pagination412-20lld:pubmed
pubmed-article:7974525pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7974525pubmed:meshHeadingpubmed-meshheading:7974525-...lld:pubmed
pubmed-article:7974525pubmed:meshHeadingpubmed-meshheading:7974525-...lld:pubmed
pubmed-article:7974525pubmed:meshHeadingpubmed-meshheading:7974525-...lld:pubmed
pubmed-article:7974525pubmed:meshHeadingpubmed-meshheading:7974525-...lld:pubmed
pubmed-article:7974525pubmed:meshHeadingpubmed-meshheading:7974525-...lld:pubmed
pubmed-article:7974525pubmed:meshHeadingpubmed-meshheading:7974525-...lld:pubmed
pubmed-article:7974525pubmed:meshHeadingpubmed-meshheading:7974525-...lld:pubmed
pubmed-article:7974525pubmed:meshHeadingpubmed-meshheading:7974525-...lld:pubmed
pubmed-article:7974525pubmed:meshHeadingpubmed-meshheading:7974525-...lld:pubmed
pubmed-article:7974525pubmed:meshHeadingpubmed-meshheading:7974525-...lld:pubmed
pubmed-article:7974525pubmed:meshHeadingpubmed-meshheading:7974525-...lld:pubmed
pubmed-article:7974525pubmed:meshHeadingpubmed-meshheading:7974525-...lld:pubmed
pubmed-article:7974525pubmed:year1994lld:pubmed
pubmed-article:7974525pubmed:articleTitleSteroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells.lld:pubmed
pubmed-article:7974525pubmed:affiliationHormone Biochemistry Laboratory, School of Medicine, University of Palermo, Italy.lld:pubmed
pubmed-article:7974525pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7974525pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7974525lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7974525lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7974525lld:pubmed